Form D · Biotechnology
Miromatrix Medical Inc.
Eden Prairie, MN · CIK 0001527096
Offering snapshot reported Jul 11, 2018 · SEC filing
- Reported sold
- $15.7M Offering amount: $15.7M
- Investors reported
- 55 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 17, 2017 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$1,712,755 → $15,719,028
- Reported investors12 → 55
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 11, 2018 | Amendment | $15,719,028 | $14,006,273vs Oct 18, 2017 | 55 | SEC filing |
| Oct 18, 2017 | Initial | $1,712,755 | No comparison | 12 | SEC filing |
| Nov 5, 2015 | Amendment | $23,776,477 | $491,987vs Aug 28, 2015 | 124 | SEC filing |
| Aug 28, 2015 | Amendment | $23,284,490 | $7,228,340vs Dec 19, 2014 | 116 | SEC filing |
| Dec 19, 2014 | Amendment | $16,056,150 | $2,680,825vs Nov 5, 2014 | 85 | SEC filing |
| Nov 5, 2014 | Amendment | $13,375,325 | $2,350,778vs Sep 18, 2014 | 65 | SEC filing |
| Sep 18, 2014 | Amendment | $11,024,547 | $1,249,977vs Sep 4, 2014 | 43 | SEC filing |
| Sep 4, 2014 | Amendment | $9,774,570 | $2,141,035vs Aug 8, 2014 | 40 | SEC filing |
| Aug 8, 2014 | Amendment | $7,633,535 | $1,497,283vs May 20, 2014 | 25 | SEC filing |
| May 20, 2014 | Amendment | $6,136,252 | $1,136,252vs Oct 16, 2013 | 9 | SEC filing |
| Oct 16, 2013 | Initial | $5,000,000 | No comparison | 1 | SEC filing |
| Jul 20, 2012 | Amendment | $5,312,856 | $199,996vs May 22, 2012 | 54 | SEC filing |
| May 22, 2012 | Amendment | $5,112,860 | $3,088,606vs Dec 2, 2011 | 50 | SEC filing |
| Dec 2, 2011 | Initial | $2,024,254 | No comparison | 34 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-296987
Series B-2 Convertible Preferred Stock
Source: Form D, filed Jul 11, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph Alexander | Executive |
| Paul Bruckman | Director |
| Paul Buckman | Director |
| Robert Cohen | Director, Executive, Promoter |
| Ronald Ebensteiner | Director |
| Ron Ebensteiner | Director |
| Ronald Eibensteiner | Director |
| John J. Erb | Director |
| Timothy Flynn | Director |
| Brian Niebur | Executive |
| Harald C. Ott | Director |
| Timothy J. Pawlenty | Director |
| Jeff Ross | Director, Executive |
| Jeffrey Ross | Director, Executive |
| Walter Sembrowich | Director |
| Doris Taylor | Promoter |
| Institute Texas Heart | Promoter |
| Regents Of University Of Minnesota | Promoter |
| Mark Wagner | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10399 West 70 Th Street
Eden Prairie, MN, 55344
Eden Prairie, MN, 55344